Asuragen Launches the AmplideX® PCR/CE C9orf72 Kit for High-Resolution Genotyping of GC-rich Repeat Expansions Relevant to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  Austin, Texas – July 6, 2016 – Asuragen Inc., a global molecular diagnostics company, announced the launch of the AmplideX PCR/CE C9orf72 Kit*.  The PCR/capillary electrophoresis-based assay leverages Asuragen’s proven, proprietary technology for analyzing high homology and GC-rich content. Asuragen has…